Gandy, Sam
Ehrlich, Michelle E.
Funding for this research was provided by:
National Institute on Aging (U01AG046170, U01AG046170)
Cure Alzheimer's Fund
Article History
Received: 17 June 2023
Accepted: 11 September 2023
First Online: 25 September 2023
Change Date: 30 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12974-023-02954-z
Declarations
:
: All studies were approved by the Icahn School of Medicine at Mount Sinai IACUC.
: Dr. Gandy is a past consultant for Diagenic and a current consultant for Gerson Lehrman Group, Third Bridge, Medacorp, Cognito, Altpep, Slingshot, Guidepoint, Vigil Neurosciences, and the Bell Law Firm. He has received research support in the past from Warner-Lambert, Pfizer, Baxter, and Avid. Dr Ehrlich has no competing interests.